PharmaRoth Labs(OTC) ROTH

PharmaRoth Labs, Inc. is a nutraceutical company focused on producing and distributing Sucanon, an herbal-based treatment for type-2 diabetes. Established in 2000 and based in Las Vegas, Nevada, the company aims to improve health outcomes through innovative products.

Products and Services

• Sucanon: An herbal-based nutraceutical for type-2 diabetes management
• Research and development of additional nutraceutical products
• Marketing and distribution services for health-related products

Growth Outlook

• Market demand for diabetes management solutions is increasing globally
• Expansion plans include new product lines targeting health-conscious consumers
• Strategic partnerships may enhance distribution capabilities and market reach

Financial Highlights

• Recent quarterly net income reported at -$22,455, indicating ongoing operational challenges
• Trailing twelve months (TTM) revenue of $0.00001, reflecting low sales volume
• Current ratio at 0.35 suggests liquidity concerns in meeting short-term obligations

PharmaRoth Labs, Inc. operates in a competitive industry with a focus on addressing significant health issues such as type-2 diabetes. The company's flagship product, Sucanon, positions it within a growing market that increasingly values natural health solutions. Despite recent financial challenges, including negative net income and low revenue, the company is exploring avenues for growth through product expansion and strategic partnerships. The current financial ratios indicate a need for improved liquidity and operational efficiency, which may be critical for future success. Investors may find interest in the company's potential to capitalize on the rising demand for effective health solutions.